Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06402643

Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium

Comparative Analysis of Recurrence Rate Between Mini-Slet (Simple Limbal Epithelial Transplantation) Versus Limbal-Conjunctival Autograft Techniques in Primary Pterygium Excision

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The surgical treatment options for pterygium, an abnormal growth on the eye's frontal surface can be treated with several surgical techniques. The rates of pterygium coming back varies depending on the surgical technique employed and other factors related to the patient and surgery. The objective of this study is to assess the efficacy and safety of incorporating a single amniotic membrane with stem cells in the treatment of primary pterygium, aiming to enhance surgical outcomes and minimize recurrence rates.

Detailed description

The surgical treatment options for pterygium, an abnormal growth on the eye's surface, encompass various approaches. These include standard surgical excision, which involves removing the pterygium using traditional surgical methods and more recently Simple Limbal Epithelial Transplantation. Recurrence rate of pterygium varies depending on the surgical technique employed and other factors related to the patient and surgery.The objective of this study is to assess the efficacy and safety of incorporating a single amniotic membrane with stem cells in the treatment of primary pterygium, aiming to enhance surgical outcomes and minimize recurrence rates.

Conditions

Interventions

TypeNameDescription
PROCEDUREPterygium ExcisionPterygium will be surgically removed utilizing conventional resection techniques, entailing a blunt resection of the head, neck, and body of the pterygium. Subsequent to the resection, the surgical site will be polished using a surgical diamond burr if deemed necessary, and hemostasis will be achieved using bipolar cautery.

Timeline

Start date
2024-06-22
Primary completion
2025-08-31
Completion
2025-12-31
First posted
2024-05-07
Last updated
2024-05-07

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT06402643. Inclusion in this directory is not an endorsement.